0000950123-15-011169.txt : 20151111 0000950123-15-011169.hdr.sgml : 20151111 20151110165725 ACCESSION NUMBER: 0000950123-15-011169 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151110 DATE AS OF CHANGE: 20151110 EFFECTIVENESS DATE: 20151110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Polaris Venture Management Co. V, L.L.C. CENTRAL INDEX KEY: 0001439589 IRS NUMBER: 204234752 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16125 FILM NUMBER: 151219571 BUSINESS ADDRESS: STREET 1: ONE MARINA PARK DRIVE STREET 2: 10TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 781-290-0770 MAIL ADDRESS: STREET 1: ONE MARINA PARK DRIVE STREET 2: 10TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001439589 XXXXXXXX 09-30-2015 09-30-2015 Polaris Venture Management Co. V, L.L.C.

ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210

13F HOLDINGS REPORT 028-16125 N John Gannon 855-787-3500 /s/ John Gannon Boston MA 11-10-2015 0 9 146773 false INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F Bind Therapeutics, Inc. Common Stock 05548N107 9001 2018253 SH SOLE 2018253 0 0 Fate Therapeutics, Inc. Common Stock 31189P102 13182 2473186 SH SOLE 2473186 0 0 Genocea Biosciences, Inc. Common Stock 372427104 13485 1968606 SH SOLE 1968606 0 0 Trevena, Inc. Common Stock 89532E109 27627 2669280 SH SOLE 2669280 0 0 Cerulean Pharma Inc Common Stock 15708Q105 12032 3287529 SH SOLE 3287529 0 0 Ocular Therapeutix, Inc. Common Stock 67576A100 17294 1230009 SH SOLE 1230009 0 0 T2 Biosystems, Inc. Common Stock 89853L104 17682 2018450 SH SOLE 2018450 0 0 Atyr Pharma Inc. Common Stock 002120103 18755 1827992 SH SOLE 1827992 0 0 Pulmatrix Inc. Common Stock 74584P103 17715 3607996 SH SOLE 3607996 0 0